Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles

Area of Science:

• Vaccinology
• Pharmaceutical Development
• Public Health Policy

Background:

• Post-approval obstacles can hinder vaccine utilization and lead to market withdrawal.
• Early intervention during vaccine development is crucial for success.
• Technological changes are more feasible earlier in the development process.

Purpose of the Study:

• To introduce augmented vaccine target product profiles (TPPs) as a tool to anticipate post-approval challenges.
• To facilitate early and effective communication among diverse vaccine stakeholders.
• To enhance the likelihood of vaccine success by proactively addressing potential obstacles.

Main Methods:

• The study proposes the use of augmented TPPs.
• It emphasizes early engagement with stakeholders including scientists, marketers, policymakers, and healthcare professionals.
• The approach focuses on identifying and mitigating potential post-approval issues during the design phase.

Main Results:

• Augmented TPPs provide a framework for anticipating and addressing potential obstacles.
• Early stakeholder engagement, facilitated by TPPs, can lead to more robust vaccine development strategies.
• Proactive identification of challenges improves a vaccine's trajectory towards successful implementation.

Conclusions:

• Augmented TPPs are a valuable tool for proactive vaccine development.
• Addressing potential post-approval obstacles early increases a vaccine's chances of success.
• Enhanced collaboration among stakeholders, guided by TPPs, is essential for navigating vaccine development and implementation challenges.